The Income Tax Department has introduced FORM 14 under the Income-tax Act, 2025 to streamline tax incentives for research and development (R&D). This new framework replaces earlier provisions and establishes a structured approval mechanism for companies operating in-house R&D facilities.
The Department of Scientific and Industrial Research (DSIR) plays a central role in granting this approval, making FORM 14 a crucial document for businesses seeking tax deductions on scientific research activities.
What is FORM 14?
FORM 14 is an official approval order issued by DSIR under Section 45(2) of the Income-tax Act, 2025 read with Rule 29 of the Income-tax Rules, 2026. It certifies that a company's in-house R&D facility meets the prescribed conditions for tax benefits.
This marks a shift from the earlier Form 3CM under the Income-tax Act, 1961, aligning compliance with the new tax regime.
Purpose of FORM 14
The introduction of FORM 14 aims to:
- Grant formal approval to in-house R&D facilities
- Define the scope and objectives of scientific research
- Link approvals with DSIR recognition
- Provide a statutory basis for claiming tax deductions
This ensures better transparency and accountability in R&D tax claims.
Who Issues and Receives FORM 14?
- Issuing Authority: Secretary, DSIR (Prescribed Authority under Rule 29)
- Recipient: The company operating the in-house R&D facility
- A copy is also shared with the jurisdictional Chief Commissioner of Income-tax
Is FORM 14 a Filing Requirement?
No, FORM 14 is not required to be filed by companies. Instead:
- It acts as an approval certificate
- Companies must retain it for verification
- It is used to support claims for deductions during assessment
Key Details Contained in FORM 14
FORM 14 includes critical information such as:
- Company name and address
- Nature of business and products
- Objectives of scientific research
- Location of R&D facility
- DSIR recognition details
- Approval confirmation under Section 45(2)
Important Conditions to Note
1. Facility-Specific Approval
Approval under FORM 14 applies only to the specific R&D facility mentioned.
2. No Automatic Deduction
Receiving FORM 14 does not guarantee tax deduction. Companies must still meet all statutory conditions.
3. Time-Bound Validity
Approval depends on:
- Validity of DSIR recognition
- Continuous compliance with tax provisions
4. Possibility of Withdrawal
Approval may be revoked in cases of:
- Non-compliance with rules
- Withdrawal of DSIR recognition
Link with Other R&D Forms
FORM 14 works alongside other compliance forms:
- FORM 11: Application and agreement
- FORM 12: Report by prescribed authority
- FORM 13: Audit report
Together, these create a comprehensive compliance framework for R&D tax benefits.
Impact on Businesses
The introduction of FORM 14 is expected to:
- Improve clarity in R&D tax approvals
- Strengthen regulatory oversight
- Encourage genuine scientific research
- Reduce ambiguity in deduction claims
However, companies must ensure strict compliance to fully benefit from these provisions.
Conclusion
FORM 14 represents a structured and transparent approach to granting tax incentives for in-house R&D under the new Income-tax regime. While it simplifies approval, businesses must remain vigilant about compliance requirements to secure and retain tax benefits.
CAclubindia
